Systolic hypertension as side effect of topical low dose atropine drops

dc.contributor.authorWasserman, Barry N.
dc.contributor.authorMassenzio, Erik
dc.contributor.authorLee, Karen
dc.contributor.authorPlager, David A.
dc.contributor.departmentOphthalmology, School of Medicine
dc.date.accessioned2024-06-13T13:08:41Z
dc.date.available2024-06-13T13:08:41Z
dc.date.issued2024-02-08
dc.description.abstractPurpose: To present a case of increased systemic hypertension and pupil dilation related to low dose atropine eyedrops. Observations: A thirteen-year-old male with progressive myopia received atropine 0.05% ophthalmic drops to slow down myopia progression. He exhibited systemic systolic hypertension, photophobia, and bilateral nonreactive mydriasis. The atropine drops were discontinued, and his blood pressure and pupillary function normalized. Conclusions and importance: This case demonstrates sensitivity to low dose atropine with increased systemic blood pressure and pupillary dilation.
dc.eprint.versionFinal published version
dc.identifier.citationWasserman BN, Massenzio E, Lee K, Plager DA. Systolic hypertension as side effect of topical low dose atropine drops. Am J Ophthalmol Case Rep. 2024;33:102004. Published 2024 Feb 8. doi:10.1016/j.ajoc.2024.102004
dc.identifier.urihttps://hdl.handle.net/1805/41523
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1016/j.ajoc.2024.102004
dc.relation.journalAmerican Journal of Ophthalmology Case Reports
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourcePMC
dc.subjectAtropine
dc.subjectMyopia
dc.subjectHypertension
dc.titleSystolic hypertension as side effect of topical low dose atropine drops
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Wasserman2024Systolic-CCBYNCND.pdf
Size:
1.73 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: